Weidenbruch John

Avg. Two Year Performance

261% Avg. Purchase Return
90% Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return13%55%84%118%261%
Purchase Success Rate1 of 11 of 11 of 11 of 11 of 1
Average Sale Return----------
Sale Success Rate----------
Drugs » Drug Manufacturers - Major

Acting General Counsel:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

Ex. VP, Gen. Counsel and Secr.:

Holdings: 35.0K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--